menu search

MDAI / Spectral AI shares surge as wound imaging device wins regulatory approvals in US and UK

Spectral AI shares surge as wound imaging device wins regulatory approvals in US and UK
Spectral AI Inc (NASDAQ:MDAI) shares surged in pre-market trade after the company announced that its DeepView SnapShot Wound Imaging System is now United Kingdom Conformity Assessed (UKCA)-marked for use in the UK and it has achieved Class 1 medical device classification from the United States Food and Drug Administration (FDA). The company's DeepView SnapShot is a patented, universal imaging platform that uses predictive artificial intelligence (AI) software to assist clinicians in making quicker and more accurate decisions in wound care. Read More
Posted: Oct 19 2023, 09:01
Author Name: Proactive Investors
Views: 112268

MDAI News  

Spectral AI taps Paul Chadwick to lead DeepView global expansion

By Proactive Investors
October 24, 2023

Spectral AI taps Paul Chadwick to lead DeepView global expansion

Spectral AI Inc (NASDAQ:MDAI) is beefing up its executive team in the UK with the addition of Prof Paul Chadwick. Chadwick, a distinguished clinical s more_horizontal

Spectral AI provides positive 2023 and 2024 revenue guidance

By Proactive Investors
October 23, 2023

Spectral AI provides positive 2023 and 2024 revenue guidance

Spectral AI Inc (NASDAQ:MDAI) has announced that its full-year 2023 revenue is expected to approximately $17.4 million, while its revenue in 2024 is e more_horizontal

Spectral AI shares surge as wound imaging device wins regulatory approvals in US and UK

By Proactive Investors
October 19, 2023

Spectral AI shares surge as wound imaging device wins regulatory approvals in US and UK

Spectral AI Inc (NASDAQ:MDAI) shares surged in pre-market trade after the company announced that its DeepView SnapShot Wound Imaging System is now Un more_horizontal

Spectral AI expands diabetic foot ulcer study to additional clinical sites

By Proactive Investors
October 16, 2023

Spectral AI expands diabetic foot ulcer study to additional clinical sites

Spectral AI Inc (NASDAQ:MDAI) announced it has added seven clinical sites to its multi-centre study of its DeepView Wound Imaging System for diabetic more_horizontal

Are Penny Stocks Worth It? 4 To Watch With Big News

By PennyStocks
October 4, 2023

Are Penny Stocks Worth It? 4 To Watch With Big News

Penny stocks, defined as stocks trading under $5 per share, are known for their volatility and potential for significant returns. However, the low pri more_horizontal


Search within

Pages Search Results: